Quantcast

Latest Cytopathology Stories

2014-05-06 08:34:15

SOUTH SAN FRANCISCO, Calif., May 6, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that four abstracts supporting the use of the company's Afirma Malignancy Classifiers and enhancing its overall Afirma solution will be presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific & Clinical Congress taking place May 14-18, 2014 in Las Vegas. Veracyte developed the Afirma Malignancy Classifiers to further expand the Afirma...

2014-05-02 08:24:46

SOUTH SAN FRANCISCO, Calif. and SAO PAULO, Brazil, May 2, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) and Fleury Medicine and Health today announced a new partnership that will make Veracyte's Afirma Gene Expression Classifier (GEC) available to patients in Brazil, helping to reduce unnecessary surgeries and potentially lower costs there as part of thyroid cancer diagnosis. Financial terms of the agreement were not disclosed. Through the agreement, Fleury, which has...

2014-05-01 08:35:55

SOUTH SAN FRANCISCO, Calif., May 1, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced today that its first quarter 2014 financial results will be released after close of market on Thursday, May 8, 2014. Following the announcement, Veracyte's management will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The live webcast and subsequent replay may be accessed by visiting...

2014-04-16 16:30:32

NORTHFIELD, Ill., April 16, 2014 /PRNewswire-USNewswire/ -- The College of American Pathologists (CAP) and the American Society of Cytopathology (ASC) announced today the signing of a memorandum of understanding (MOU) to collaborate on initiatives to advance the delivery of cytopathology services and improve patient care. http://photos.prnewswire.com/prnvar/20140416/75656 The non-exclusive collaboration will enhance the relationship between the two organizations to advocate excellence in the...

2014-04-15 12:28:49

RnRMarketResearch.com adds "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" to its store. DALLAS, April 15, 2014 /PRNewswire-iReach/ -- This report provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report...

2014-04-09 12:31:53

DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer) has announced the addition of the "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" [http://www.researchandmarkets.com/research/cdqkxc/cervical_cancer ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cervical cancer is one of the deadliest...

2014-03-17 08:28:49

SOUTH SAN FRANCISCO, Calif., March 17, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointments of two executives to its management team. Julie A. Brooks joins the company as executive vice president, general counsel and secretary; and Andy Thorson joins as executive vice president, corporate strategy and business development. "I am thrilled to welcome Julie Brooks and Andy...

2014-03-11 08:29:14

SOUTH SAN FRANCISCO, Calif., March 11, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its fourth quarter and full-year 2013 financial results after close of market on Tuesday, March 18, 2014. Following the release, Veracyte will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial results and business progress. The live webcast and subsequent replay may be accessed by visiting Veracyte's website...

2014-03-03 16:25:19

-- Presentation and Webcast Scheduled for Tuesday, March 4, at 8 a.m. ET -- SOUTH SAN FRANCISCO, Calif., March 3, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced a change in the company's presentation date and time at the Cowen and Company 34(th) Annual Health Care Conference. Bonnie H. Anderson, president and chief executive officer, will present on Tuesday, March 4, 2014 at 8:00 a.m. ET in the St. Botolph room at The Boston Marriott Copley Place in Boston, Mass....

2014-03-01 23:01:46

Korean researchers say a combination of techniques improves diagnostic accuracy for several types of Non-Hodgkin’s Lymphoma. Raleigh, NC (PRWEB) March 01, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on encouraging new research published in a medical journal called Diagnostic Cytopathology. Researchers from Yonsei University College of Medicine compared the diagnostic accuracy of two cell testing techniques and found that, when used together, they make it possible to not only...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related